ArticleBMC cancer2025

Prevalence and therapeutic response of EGFR T790I mutation in NSCLC patients with acquired resistance to EGFR-TKIs: a retrospective cohort study.

Jingwei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.